Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating dexmedetomidine for postoperative analgesia after bariatric surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Obesity, Sleep Apnea | Phase 2, Phase 3 | Status: COMPLETED